Home » Topics » BioWorld Science

BioWorld Science
RSS

Sex disparities of lupus recapitulated in mouse model

April 25, 2022

PKMYT1 targeting useful for the treatment of CCNE1-amplified cancers

April 25, 2022

PAX8-SOX17 tandem involved in tumor angiogenesis

April 25, 2022

New HIF-2alpha PET tracer presented by University of Texas System

April 25, 2022

Yonsei University presents new SLC26A4 inhibitors

April 25, 2022

Chinese researchers identify new anti-claudin18.2 ADCs

April 25, 2022

Gilead Sciences discloses new HIV antivirals

April 25, 2022

CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo

April 25, 2022

Chinese investigators patent new THR-beta agonists

April 25, 2022

CLN-978, a next-generation CD19-targeted therapeutic for the treatment of B-cell malignancies

April 25, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...